Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	translation release factor complex	GSPT1 GSPT2	1.31e-04	3	139	2	GO:0018444
Domain	Cadherin_CS	FAT4 DSC2 PCDHGB2 PCDH17 CELSR3 PCDHGA12 PCDH8	1.49e-05	109	136	7	IPR020894
Domain	CADHERIN_1	FAT4 DSC2 PCDHGB2 PCDH17 CELSR3 PCDHGA12 PCDH8	1.89e-05	113	136	7	PS00232
Domain	Cadherin	FAT4 DSC2 PCDHGB2 PCDH17 CELSR3 PCDHGA12 PCDH8	1.89e-05	113	136	7	PF00028
Domain	CADHERIN_2	FAT4 DSC2 PCDHGB2 PCDH17 CELSR3 PCDHGA12 PCDH8	2.00e-05	114	136	7	PS50268
Domain	-	FAT4 DSC2 PCDHGB2 PCDH17 CELSR3 PCDHGA12 PCDH8	2.00e-05	114	136	7	2.60.40.60
Domain	CA	FAT4 DSC2 PCDHGB2 PCDH17 CELSR3 PCDHGA12 PCDH8	2.12e-05	115	136	7	SM00112
Domain	Cadherin-like	FAT4 DSC2 PCDHGB2 PCDH17 CELSR3 PCDHGA12 PCDH8	2.24e-05	116	136	7	IPR015919
Domain	Cadherin	FAT4 DSC2 PCDHGB2 PCDH17 CELSR3 PCDHGA12 PCDH8	2.50e-05	118	136	7	IPR002126
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	CYC1 CDKN2A PDE3B DSC2 HECTD3 SGSH CYP51A1 DNAH2 CD46 CTDNEP1 ZFPL1 SEMA4C GGT7 JAG2 SLC19A1 ITM2B TOR1AIP1 C8orf33 SEC23A	7.75e-09	942	139	19	31073040
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	HSPG2 FLNC SHROOM3 LRFN1 EPPK1 ARID1A CTDNEP1 CIT ZDHHC8 SH2B2 ELAC2 C6orf132 GGT7 JAG2 CELSR3 NAV2 NAV1 OGDHL IRS2 DHX34	1.84e-08	1105	139	20	35748872
Pubmed	The processed isoform of the translation termination factor eRF3 localizes to the nucleus to interact with the ARF tumor suppressor.	CDKN2A GSPT1 GSPT2	6.25e-08	3	139	3	24569073
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	SHROOM3 LRFN1 GIT1 ZNF318 KANK2 CIT RPH3A NLGN3 AGO1 FAM120A NAV1 CDK5RAP2 FRMPD3 PCDH8 SEC23A TP53BP2 FERMT3	3.33e-07	963	139	17	28671696
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	KIAA1549 MED4 CELSR3 CADPS NAV1 CDK5RAP2 NFAT5	9.81e-07	130	139	7	12421765
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	HSPG2 FAT4 RNF31 IST1 PQBP1 PCDH17 GSPT1 JAG2 QSOX1 RBM14 LNX1 PCDH8 TP53BP2	1.09e-06	608	139	13	16713569
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	CYC1 FLNC GIT1 PCLO KIAA1549 ARID1A KANK2 CIT RPH3A SLC25A3 NLGN3 AGO1 FAM120A CADPS RBM14 NAV1 OGDHL SEC23A GOT2 TP53BP2	1.13e-06	1431	139	20	37142655
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	PDE3B KIAA1549 ZNF318 ARID1A ZDHHC8 C6orf132 RBM14 TOR1AIP1 TP53BP2	1.23e-06	263	139	9	34702444
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	HSPG2 FAT4 B3GNT9 FOLR1 SGSH CYP51A1 KIAA1549 RNF213 LAMC1 CD46 ELAC2 GGT7 JAG2 CELSR3 ITM2B TOR1AIP1 PLXNB1 GALNT4	1.54e-06	1201	139	18	35696571
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	MYC CDKN2A RNF31 DSC2 HECTD3 KIAA1549 RNF213 ZNF318 ARID1A KANK2 FCSK FAM120A CADPS CLMP IRS2 TAF6 DHX34	2.49e-06	1116	139	17	31753913
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	CYC1 CDKN2A HSPG2 FLNC DSC2 GBE1 RNF213 LAMC1 ARID1A CBL ZFPL1 SLC25A3 PARP10 MRPL14 CPT1C OGDHL ITM2B SEC23A GOT2	5.51e-06	1451	139	19	30550785
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	CDKN2A SHROOM3 PDE3B DSC2 GIT1 LAMC1 CRTC1 CBL C6orf132 RBM14 NAV2 NAV1 IRS2 TP53BP2	9.83e-06	861	139	14	36931259
Pubmed	Pax6 interactions with chromatin and identification of its novel direct target genes in lens and forebrain.	FAT4 TRPM3 NAV1	1.34e-05	12	139	3	23342162
Pubmed	The structure of the human betaII-tryptase tetramer: fo(u)r better or worse.	TPSAB1 TPSB2	1.59e-05	2	139	2	10500112
Pubmed	Involvement of human release factors eRF3a and eRF3b in translation termination and regulation of the termination complex formation.	GSPT1 GSPT2	1.59e-05	2	139	2	15987998
Pubmed	Ink4/Arf locus restores glucose tolerance and insulin sensitivity by reducing hepatic steatosis and inflammation in mice with impaired IRS2-dependent signalling.	CDKN2A IRS2	1.59e-05	2	139	2	26022372
Pubmed	Characterization of two highly polymorphic human tryptase loci and comparison with a newly discovered monkey tryptase ortholog.	TPSAB1 TPSB2	1.59e-05	2	139	2	10898108
Pubmed	p19ARF is a critical mediator of both cellular senescence and an innate immune response associated with MYC inactivation in mouse model of acute leukemia.	MYC CDKN2A	1.59e-05	2	139	2	25784651
Pubmed	Induction of ectopic Myc target gene JAG2 augments hypoxic growth and tumorigenesis in a human B-cell model.	MYC JAG2	1.59e-05	2	139	2	20133585
Pubmed	Folate transport gene inactivation in mice increases sensitivity to colon carcinogenesis.	FOLR1 SLC19A1	1.59e-05	2	139	2	15705887
Pubmed	Human beta-tryptase is a ring-like tetramer with active sites facing a central pore.	TPSAB1 TPSB2	1.59e-05	2	139	2	9521329
Pubmed	Expression and differential polarization of the reduced-folate transporter-1 and the folate receptor alpha in mammalian retinal pigment epithelium.	FOLR1 SLC19A1	1.59e-05	2	139	2	10787414
Pubmed	Human tryptases alpha and beta/II are functionally distinct due, in part, to a single amino acid difference in one of the surface loops that forms the substrate-binding cleft.	TPSAB1 TPSB2	1.59e-05	2	139	2	10391906
Pubmed	Myc-ARF (alternate reading frame) interaction inhibits the functions of Myc.	MYC CDKN2A	1.59e-05	2	139	2	15199070
Pubmed	HECTD3 promotes gastric cancer progression by mediating the polyubiquitination of c-MYC.	MYC HECTD3	1.59e-05	2	139	2	35397617
Pubmed	Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes.	FAT4 ARID1A	1.59e-05	2	139	2	22484628
Pubmed	High expression of folate receptor alpha in lung cancer correlates with adenocarcinoma histology and EGFR [corrected] mutation.	FOLR1 SLC19A1	1.59e-05	2	139	2	22729036
Pubmed	Characterization of a tryptase mRNA expressed in the human basophil cell line KU812.	TPSAB1 TPSB2	1.59e-05	2	139	2	8434231
Pubmed	Expression of P16 in NUT carcinomas with no association with human papillomavirus (HPV).	CDKN2A NUTM1	1.59e-05	2	139	2	24185123
Pubmed	Paradoxical impact of two folate receptors, FRα and RFC, in ovarian cancer: effect on cell proliferation, invasion and clinical outcome.	FOLR1 SLC19A1	1.59e-05	2	139	2	23144806
Pubmed	Cloning and characterization of a second complementary DNA for human tryptase.	TPSAB1 TPSB2	1.59e-05	2	139	2	2203827
Pubmed	Structural characterization of a novel Cbl phosphotyrosine recognition motif in the APS family of adapter proteins.	CBL SH2B2	1.59e-05	2	139	2	15737992
Pubmed	Human mast cell tryptase: multiple cDNAs and genes reveal a multigene serine protease family.	TPSAB1 TPSB2	1.59e-05	2	139	2	2187193
Pubmed	c-Myc deregulation induces mRNA capping enzyme dependency.	MYC RNGTT	1.59e-05	2	139	2	27756891
Pubmed	Structural requirements and mechanism for heparin-dependent activation and tetramerization of human betaI- and betaII-tryptase.	TPSAB1 TPSB2	1.59e-05	2	139	2	15567416
Pubmed	The human mast cell tryptase tetramer: a fascinating riddle solved by structure.	TPSAB1 TPSB2	1.59e-05	2	139	2	10708850
Pubmed	Functional role of Tia1/Pub1 and Sup35 prion domains: directing protein synthesis machinery to the tubulin cytoskeleton.	GSPT1 GSPT2	1.59e-05	2	139	2	24981173
Pubmed	Tryptase haplotype in mastocytosis: relationship to disease variant and diagnostic utility of total tryptase levels.	TPSAB1 TPSB2	1.59e-05	2	139	2	17449330
Pubmed	Thoracic nuclear protein in testis (NUT) carcinoma: expanded pathological spectrum with expression of thyroid transcription factor-1 and neuroendocrine markers.	NUTM1 NKX2-1	1.59e-05	2	139	2	33231320
Pubmed	Impact of naturally forming human α/β-tryptase heterotetramers in the pathogenesis of hereditary α-tryptasemia.	TPSAB1 TPSB2	1.59e-05	2	139	2	31337736
Pubmed	Derivation of genetic biomarkers for cancer risk stratification in Barrett's oesophagus: a prospective cohort study.	MYC CDKN2A	1.59e-05	2	139	2	26104750
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	PCDHGB2 PCDH17 CELSR3 PCDHGA12 PCDH8	1.79e-05	80	139	5	10716726
Pubmed	Src homology 2 (SH2)-containing 5'-inositol phosphatase localizes to podosomes, and the SH2 domain is implicated in the attenuation of bone resorption in osteoclasts.	DOK3 CBL SEC23A	2.74e-05	15	139	3	16601135
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	CYC1 SHROOM3 RNGTT IST1 CRTC1 MSL1 ZNF318 SSBP3 PQBP1 KANK2 CIT C6orf132 SEMA4C SLC25A3 MED4 TAF6 ITM2B C8orf33	3.08e-05	1497	139	18	31527615
Pubmed	Ocular retardation mouse caused by Chx10 homeobox null allele: impaired retinal progenitor proliferation and bipolar cell differentiation.	CHRNA3 JAG2 ROM1	3.37e-05	16	139	3	8630490
Pubmed	Expression Analysis of p16, c-Myc, and mSin3A in Non-small Cell Lung Cancer by Computer Aided Scoring and Analysis (CASA).	MYC CDKN2A	4.75e-05	3	139	2	26118188
Pubmed	QM-FISH analysis of the genes involved in the G1/S checkpoint signaling pathway in triple-negative breast cancer.	MYC CDKN2A	4.75e-05	3	139	2	24096545
Pubmed	AMPK promotes survival of c-Myc-positive melanoma cells by suppressing oxidative stress.	MYC CDKN2A	4.75e-05	3	139	2	29440228
Pubmed	Altered mucosal DNA methylation in parallel with highly active Helicobacter pylori-related gastritis.	FLNC HAND1	4.75e-05	3	139	2	23292007
Pubmed	Impact of 9p deletion and p16, Cyclin D1, and Myc hyperexpression on the outcome of anaplastic oligodendrogliomas.	MYC CDKN2A	4.75e-05	3	139	2	29489901
Pubmed	Polypeptide chain release factor eRF3 is a novel molecular partner of survivin.	GSPT1 GSPT2	4.75e-05	3	139	2	23377885
Pubmed	Biomarker-driven phase 2 umbrella trial study for patients with recurrent small cell lung cancer failing platinum-based chemotherapy.	MYC CDKN2A	4.75e-05	3	139	2	32584426
Pubmed	Expression of folate transporters in human placenta and implications for homocysteine metabolism.	FOLR1 SLC19A1	4.75e-05	3	139	2	20036773
Pubmed	Characterization of genes encoding known and novel human mast cell tryptases on chromosome 16p13.3.	TPSAB1 TPSB2	4.75e-05	3	139	2	9920877
Pubmed	Arf tumor suppressor disrupts the oncogenic positive feedback loop including c-Myc and DDX5.	MYC CDKN2A	4.75e-05	3	139	2	24469041
Pubmed	Dynamic epigenetic regulation of glioblastoma tumorigenicity through LSD1 modulation of MYC expression.	MYC CDKN2A	4.75e-05	3	139	2	26159421
Pubmed	Reduced c-Myc signaling triggers telomere-independent senescence by regulating Bmi-1 and p16(INK4a).	MYC CDKN2A	4.75e-05	3	139	2	16537449
Pubmed	Amino acid-dependent signaling via S6K1 and MYC is essential for regulation of rDNA transcription.	MYC CRTC1	4.75e-05	3	139	2	27385002
Pubmed	Treatments, prognostic factors, and genetic heterogeneity in advanced cholangiocarcinoma: A multicenter real-world study.	CDKN2A ARID1A	4.75e-05	3	139	2	38457226
Pubmed	Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.	MYC CDKN2A	4.75e-05	3	139	2	11604501
Pubmed	Molecular cloning of a novel member of the eukaryotic polypeptide chain-releasing factors (eRF). Its identification as eRF3 interacting with eRF1.	GSPT1 GSPT2	4.75e-05	3	139	2	9712840
Pubmed	cBAF complex components and MYC cooperate early in CD8+ T cell fate.	MYC ARID1A	4.75e-05	3	139	2	35732731
Pubmed	Expression of PIK3IP1 in the murine uterus during early pregnancy.	ARID1A PIK3IP1	4.75e-05	3	139	2	29289536
Pubmed	ARID1A suppresses malignant transformation of human pancreatic cells via mediating senescence-associated miR-503/CDKN2A regulatory axis.	CDKN2A ARID1A	4.75e-05	3	139	2	28942143
Pubmed	Neuron navigator: a human gene family with homology to unc-53, a cell guidance gene from Caenorhabditis elegans.	NAV2 NAV1	4.75e-05	3	139	2	12079279
Pubmed	Sensory deficits in mice hypomorphic for a mammalian homologue of unc-53.	NAV2 NAV1	4.75e-05	3	139	2	15158073
Pubmed	G1 arrest by p16INK4A uncouples growth from cell cycle progression in leukemia cells with deregulated cyclin E and c-Myc expression.	MYC CDKN2A	4.75e-05	3	139	2	15800668
Pubmed	Dynamic subcellular localization of the mono-ADP-ribosyltransferase ARTD10 and interaction with the ubiquitin receptor p62.	MYC PARP10	4.75e-05	3	139	2	22992334
Pubmed	Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.	MYC CDKN2A	4.75e-05	3	139	2	10541552
Pubmed	Decreased placental folate transporter expression and activity in first and second trimester in obese mothers.	FOLR1 SLC19A1	4.75e-05	3	139	2	31926453
Pubmed	Pore membrane and/or filament interacting like protein 1 (POMFIL1) is predominantly expressed in the nervous system and encodes different protein isoforms.	NAV2 NAV1	4.75e-05	3	139	2	12062803
Pubmed	The APS adapter protein couples the insulin receptor to the phosphorylation of c-Cbl and facilitates ligand-stimulated ubiquitination of the insulin receptor.	CBL SH2B2	4.75e-05	3	139	2	10854852
Pubmed	p14ARF directly interacts with Myc through the Myc BoxII domain.	MYC CDKN2A	4.75e-05	3	139	2	16410719
Pubmed	Folate transporter dynamics and therapy with classic and tumor-targeted antifolates.	FOLR1 SLC19A1	4.75e-05	3	139	2	33737637
Pubmed	Human subjects are protected from mast cell tryptase deficiency despite frequent inheritance of loss-of-function mutations.	TPSAB1 TPSB2	4.75e-05	3	139	2	19748655
Pubmed	DNA methylation and expression of the folate transporter genes in colorectal cancer.	FOLR1 SLC19A1	4.75e-05	3	139	2	25697897
Pubmed	Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	KIAA1549 RNF213 TRPM3 RAVER2 CDK5RAP2	5.52e-05	101	139	5	10997877
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SHROOM3 SMCHD1 KIAA1549 CRTC1 CELSR3 NAV2 CDK5RAP2 HHIPL1 DHX34 PLXNB1	5.63e-05	529	139	10	14621295
Pubmed	FGF signaling regulates development by processes beyond canonical pathways.	CDKN2A NKX2-1 IRS2	5.78e-05	19	139	3	33184218
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	EPPK1 LAMC1 MSL1 ARID1A MRPL14 NAV1 ALPK2 TP53BP2	6.04e-05	332	139	8	37433992
Pubmed	Prediction of the coding sequences of unidentified human genes. XVII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	SHROOM3 LRFN1 DNAH2 KANK2 NLGN3	6.06e-05	103	139	5	10819331
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	FAT4 SHROOM3 RNGTT DSC2 RNF213 ZNF318 SEMA4C SLC19A1 RBM14 CDK5RAP2 TOR1AIP1 SEC23A	7.13e-05	777	139	12	35844135
Pubmed	Protein phosphatase 1γ isoforms linked interactions in the brain.	TACC2 ZNF318 TOR1AIP1 TP53BP2	8.19e-05	57	139	4	23080069
Pubmed	Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression.	CYC1 ACO1 SLC25A33 ACSS1 ELAC2 SLC25A3 MRPL14 CPT1C OGDHL ALDH9A1 MYL10 SLC25A48 GOT2	9.24e-05	926	139	13	20877624
Pubmed	Oridonin induces apoptosis and senescence in colorectal cancer cells by increasing histone hyperacetylation and regulation of p16, p21, p27 and c-myc.	MYC CDKN2A	9.47e-05	4	139	2	21054888
Pubmed	A MYC-aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer.	MYC CDKN2A	9.47e-05	4	139	2	27213815
Pubmed	Apoptosis triggered by Myc-induced suppression of Bcl-X(L) or Bcl-2 is bypassed during lymphomagenesis.	MYC CDKN2A	9.47e-05	4	139	2	11438662
Pubmed	A fluorescence correlation spectroscopy-based assay for fragment screening of slowly inhibiting protein-peptide interaction inhibitors.	CBL SH2B2	9.47e-05	4	139	2	20298671
Pubmed	The association between the SH2-containing inositol polyphosphate 5-Phosphatase 2 (SHIP2) and the adaptor protein APS has an impact on biochemical properties of both partners.	CBL SH2B2	9.47e-05	4	139	2	17620296
Pubmed	Expression of Galectin-3, CD138, p16INK4a, and TTF-1 in mucinous bronchioloalveolar adenocarcinoma after Hodgkin lymphoma.	CDKN2A NKX2-1	9.47e-05	4	139	2	18997617
Pubmed	Glycogen-branching enzyme deficiency leads to abnormal cardiac development: novel insights into glycogen storage disease IV.	MYC GBE1	9.47e-05	4	139	2	21075835
Pubmed	Genes involved with folate uptake and distribution and their association with colorectal cancer risk.	FOLR1 SLC19A1	9.47e-05	4	139	2	20037791
Pubmed	Array comparative genome hybridization for tumor classification and gene discovery in mouse models of malignant melanoma.	CDKN2A CYP51A1	9.47e-05	4	139	2	14500367
Pubmed	Thyroid bud morphogenesis requires CDC42- and SHROOM3-dependent apical constriction.	SHROOM3 NKX2-1	9.47e-05	4	139	2	26772200
Pubmed	Antagonistic interaction between Ezh2 and Arid1a coordinates root patterning and development via Cdkn2a in mouse molars.	CDKN2A ARID1A	9.47e-05	4	139	2	31259687
Pubmed	Structural insights into eRF3 and stop codon recognition by eRF1.	GSPT1 GSPT2	9.47e-05	4	139	2	19417105
Pubmed	Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response.	MYC CDKN2A	9.47e-05	4	139	2	17728759
Pubmed	Primary and essential role of the adaptor protein APS for recruitment of both c-Cbl and its associated protein CAP in insulin signaling.	CBL SH2B2	9.47e-05	4	139	2	15031295
Pubmed	[Abnormal expression of c-myc, p53, p16 protein and GNAS1 gene mutation in fibrous dysplasia].	MYC CDKN2A	9.47e-05	4	139	2	19575869
Pubmed	Growing Mouse Oocytes Transiently Activate Folate Transport via Folate Receptors As They Approach Full Size.	FOLR1 SLC19A1	9.47e-05	4	139	2	27122634
Interaction	ARHGEF6 interactions	CDKN2A GIT1 CBL CIT NUTM1 MED4 TMEM108 TP53BP2	3.65e-07	100	135	8	int:ARHGEF6
Interaction	RYK interactions	MYC FAT4 DSC2 PCDH17 CELSR3 PCDHGA12 SLC19A1 ITM2B SEC23A	1.32e-05	212	135	9	int:RYK
Interaction	LMBR1L interactions	CYC1 CDKN2A PDE3B DSC2 HECTD3 SGSH CYP51A1 DNAH2 CD46 CTDNEP1 ZFPL1 SEMA4C GGT7 JAG2 SLC19A1 ITM2B TOR1AIP1 C8orf33 SEC23A	1.81e-05	946	135	19	int:LMBR1L
Interaction	TMEM30B interactions	LRFN1 DSC2 PCDH17 SEMA4C JAG2 CELSR3	2.29e-05	85	135	6	int:TMEM30B
Cytoband	Ensembl 112 genes in cytogenetic band chr16q22	B3GNT9 IST1 ZDHHC1 FCSK NFAT5	2.49e-04	183	139	5	chr16q22
Cytoband	16q22.1	B3GNT9 ZDHHC1 FCSK NFAT5	3.62e-04	110	139	4	16q22.1
Cytoband	8q24.3	CYC1 EPPK1 PARP10 C8orf33	4.01e-04	113	139	4	8q24.3
Cytoband	13q21.1	PCDH17 PCDH8	6.95e-04	13	139	2	13q21.1
ToppCell	droplet-Thymus-nan-3m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYC CRTC1 SSBP3 ZDHHC8 PIK3IP1 GSPT2 MYL10 MFSD13A TEDC1	4.19e-09	174	139	9	0fccd90ef72ec2e5eb369fe6d6d126c60886485a
ToppCell	droplet-Thymus-nan-3m-Lymphocytic-DN3_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYC CRTC1 SSBP3 ZDHHC8 PIK3IP1 GSPT2 MYL10 MFSD13A TEDC1	4.19e-09	174	139	9	b2fc2a756f8e373ad903bd416d9de703d945fa1c
ToppCell	Control-Epithelial-Club\|Control / Disease state, Lineage and Cell class	CPAMD8 SHROOM3 FOLR1 SGPP2 TACC2 C6orf132 NAV2 TMEM108	1.66e-07	192	139	8	d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16
ToppCell	mild-Myeloid-Neutrophils_3\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	SMCHD1 DOK3 MSL1 CD46 RPH3A IRS2 ITM2B DHX34	1.94e-07	196	139	8	9c351306b6aae68ed47d4cb1911957bf67f9e1ae
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	FAT4 KIAA1549 ARID1A CTDNEP1 PCDH17 FAM120A NAV1 IRS2	2.18e-07	199	139	8	358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCell	Healthy_donor-B_cell\|World / disease group, cell group and cell class (v2)	SH3TC2 CIT ZDHHC8 GGT7 TRPM3 FSBP PLXNB1	4.70e-07	150	139	7	a2dfed562de7f58f902b547acec5a13853c80c4c
ToppCell	Mild-Myeloid-Mast\|Mild / Condition, Lineage, Cell class and cell subclass	TPSAB1 HSPG2 SIGLEC8 KANK2 PCDHGA12 CADPS TPSB2	8.92e-07	165	139	7	5fa9552c37890c5cc7e672a47038aebba2413cb4
ToppCell	Mild-Myeloid-Mast-\|Mild / Condition, Lineage, Cell class and cell subclass	TPSAB1 HSPG2 SIGLEC8 KANK2 PCDHGA12 CADPS TPSB2	8.92e-07	165	139	7	93d3909a0f5f43d473d5005c842d7d73e25eceed
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 HSPG2 FAT4 RNF31 NAV2 CLMP HHIPL1	1.13e-06	171	139	7	972fab891135bd755d5526cbc5a963200067b0a6
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 HSPG2 FAT4 RNF31 NAV2 CLMP HHIPL1	1.13e-06	171	139	7	2a77ed79c6f2e700e789c80451a70ecb31639719
ToppCell	10x5'-GI_small-bowel-Mast\|GI_small-bowel / Manually curated celltypes from each tissue	TPSAB1 HSPG2 DOK3 KIAA1549 KANK2 CADPS TPSB2	1.27e-06	174	139	7	e94c980b25edfd0e8598c416828801fcc00e8ead
ToppCell	10x5'-GI_small-bowel-Mast-Mast_cells\|GI_small-bowel / Manually curated celltypes from each tissue	TPSAB1 HSPG2 DOK3 KIAA1549 KANK2 CADPS TPSB2	1.27e-06	174	139	7	05525bf0a2bde2be4f7c147b17a24530ce8819e0
ToppCell	Control-Epithelial-Club\|World / Disease state, Lineage and Cell class	CPAMD8 SHROOM3 FOLR1 SGPP2 TACC2 NAV2 TMEM108	1.99e-06	186	139	7	9798428691408e17ff2af2fe2d1b345f074d67e4
ToppCell	facs-Aorta-Heart-3m-Mesenchymal\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNC B3GNT9 EPPK1 TMEM108 IRS2 ALPK2 PLXNB1	2.45e-06	192	139	7	0dc1f46e40346ed0b286e53b106a812441575100
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MYC CDKN2A FLNC RNF31 GBE1 NPC1L1 NAV2	3.10e-06	199	139	7	85bb28369e0568b7b3bda095722102fc793f60ef
ToppCell	Bronchial-10x5prime-Epithelial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SHROOM3 FOLR1 SGPP2 TACC2 C6orf132 NKX2-1 PLXNB1	3.21e-06	200	139	7	d3ee5f79513e2ac02ad3329b59e6290d457c44d2
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_D\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	LRFN1 RNF31 ZNF318 PRRT3 MMP19 DHX34	7.17e-06	148	139	6	10dcbdb47cac908648d9d652c8095b536db19b8a
ToppCell	Healthy_donor-B_cell\|Healthy_donor / disease group, cell group and cell class (v2)	SH3TC2 CIT GGT7 TRPM3 FSBP PLXNB1	8.35e-06	152	139	6	5768edfde8010324d8594815e73bbfba2c3045f3
ToppCell	356C-Myeloid-Mast_cell\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	TPSAB1 SIGLEC8 DNAH2 CADPS TMEM108 TPSB2	1.29e-05	164	139	6	b3192c443f4848e6a8afdb89c155f9ec42a154b0
ToppCell	356C-Myeloid-Mast_cell-\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	TPSAB1 SIGLEC8 DNAH2 CADPS TMEM108 TPSB2	1.29e-05	164	139	6	f7288ec4daf494dae770ea6c58bead27660ccae1
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic-Mast_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TPSAB1 PDE3B KIAA1549 CADPS IRS2 TPSB2	1.63e-05	171	139	6	ac37c80c832504986c7a201d84f4b6aff5e5f323
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TPSAB1 PDE3B KIAA1549 CADPS IRS2 TPSB2	1.63e-05	171	139	6	b6502a81df4f25660f3ae4b7443a1d999df2d32b
ToppCell	5'-Adult-Appendix-Hematopoietic-Myeloid-Mast_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TPSAB1 PCDHGB2 SIGLEC8 KIAA1549 CADPS TPSB2	1.74e-05	173	139	6	a7dee23b1d43d3070d502487af319ff81a9a747b
ToppCell	E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RNGTT HECTD3 JAG2 NKX2-1 TMEM108 NFAT5	1.86e-05	175	139	6	711ace94fa9a763c6ae48171a690953f25deebe4
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CPAMD8 SHROOM3 TACC2 CIT PCDH17 TMEM108	2.05e-05	178	139	6	f5ed4a6e3eb8056b1be1fb311021710c95bdf888
ToppCell	facs-Large_Intestine-Proximal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPPK1 FOLR1 C8orf74 NAV2 OGDHL TMEM108	2.05e-05	178	139	6	09a215a0d6e98e4bb920cabda12af08ff4de3c98
ToppCell	COVID-19-Epithelial_cells-AT1\|COVID-19 / group, cell type (main and fine annotations)	THSD4 SHROOM3 TACC2 NKX2-1 SLC19A1 NAV2	2.11e-05	179	139	6	a0b33bd69ffdfd5d38d80207fb40058a490aa19e
ToppCell	3'_v3-bone_marrow-Mast\|bone_marrow / Manually curated celltypes from each tissue	TPSAB1 HSPG2 SIGLEC8 KIAA1549 CADPS TPSB2	2.18e-05	180	139	6	b37ee81b792213d6595b4ec65d04bc35d83321c7
ToppCell	3'_v3-bone_marrow-Mast-Mast_cells\|bone_marrow / Manually curated celltypes from each tissue	TPSAB1 HSPG2 SIGLEC8 KIAA1549 CADPS TPSB2	2.25e-05	181	139	6	30ec4635474ee0f0ea1415ec0ba7f008d97e8c1a
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	THSD4 SHROOM3 SGPP2 CD46 NKX2-1 NAV2	2.25e-05	181	139	6	576da14ab3107f89e1f44a4a439d1bef5bb42370
ToppCell	Control-Epithelial_cells-Airway_club\|Control / group, cell type (main and fine annotations)	CPAMD8 SHROOM3 SGPP2 TACC2 CIT NAV2	2.25e-05	181	139	6	c755d23dd9aabc717dc73e2b3fa99a1f751e6507
ToppCell	Children_(3_yrs)-Immune-enucleated_erythrocyte-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FOLR1 KIAA1549 CIT PCDH17 C6orf132 JAG2	2.32e-05	182	139	6	3fddadb2ff75013ec6eeb415872667a6bae1da2d
ToppCell	3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CDKN2A SHROOM3 DNAH2 ZDHHC1 CCDC78 C6	2.39e-05	183	139	6	58847e8f3a7ce3e33adba9477bcd55e769a64a90
ToppCell	facs-Lung-EPCAM-3m-Epithelial-Basal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPPK1 DSC2 GGT7 NKX2-1 TMEM108 LNX1	2.39e-05	183	139	6	ecac1cfaff7553a60305b34d6cede6973ffb5430
ToppCell	E15.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	FLNC MINAR2 B3GNT9 DSC2 FOLR1 TMEM108	2.39e-05	183	139	6	274f274cf60daa30d6a4cd603a3af7823bfb8016
ToppCell	facs-Lung-EPCAM-3m-Epithelial-respiratory_basal_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPPK1 DSC2 GGT7 NKX2-1 TMEM108 LNX1	2.39e-05	183	139	6	f6ebfd7f61e912f92bd07313cc213a171747ac03
ToppCell	3'_v3-lymph-node_spleen-Mast\|lymph-node_spleen / Manually curated celltypes from each tissue	TPSAB1 HSPG2 SIGLEC8 KIAA1549 CADPS TPSB2	2.47e-05	184	139	6	83675c7a083c52fb74dc8b9d35df0ef69715f707
ToppCell	3'_v3-lymph-node_spleen-Mast-Mast_cells\|lymph-node_spleen / Manually curated celltypes from each tissue	TPSAB1 HSPG2 SIGLEC8 KIAA1549 CADPS TPSB2	2.47e-05	184	139	6	ed266bd2d12f86e8786473e64fbcd58319cd4c2a
ToppCell	Transplant_Alveoli_and_parenchyma-Immune-Mast_cells\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	TPSAB1 SIGLEC8 KIAA1549 PIK3IP1 CADPS TPSB2	2.54e-05	185	139	6	a6e5328801c233a44153420e2cdae644b253f540
ToppCell	COVID-19-Epithelial_cells-Airway_club\|COVID-19 / group, cell type (main and fine annotations)	THSD4 SHROOM3 SGPP2 TACC2 NKX2-1 NAV2	2.54e-05	185	139	6	cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCell	10x5'-Lung-Mast\|Lung / Manually curated celltypes from each tissue	TPSAB1 HSPG2 SIGLEC8 KIAA1549 CADPS TPSB2	2.70e-05	187	139	6	f8ac5ca5cbe9c6f3d8c0fffc20fe08ca1aea43c0
ToppCell	10x5'-Lung-Mast-Mast_cells\|Lung / Manually curated celltypes from each tissue	TPSAB1 HSPG2 SIGLEC8 KIAA1549 CADPS TPSB2	2.70e-05	187	139	6	da275d2c774b3e6a8ed77f777dd0676ecf2ddd2c
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 SLC25A33 ACSS1 SGPP2 NAV2 LNX1	2.70e-05	187	139	6	7ea8731288e2a99f45e3958590ee1d76f49ae888
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_granulocytic\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	TPSAB1 DSC2 KIAA1549 RPH3A CADPS TPSB2	2.78e-05	188	139	6	36ff615154d6d9e3ba6ccb73a0f11574bcbf5ece
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	MYC PDE3B SMCHD1 GSPT1 PIK3IP1 IRS2	2.78e-05	188	139	6	939790f133eac9c12d08db6ddb5f08f5107844e3
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	THSD4 SHROOM3 SGPP2 TACC2 NKX2-1 NAV2	2.78e-05	188	139	6	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	HSPG2 SHROOM3 SGPP2 C6orf132 QSOX1 NAV2	2.78e-05	188	139	6	43a3a59f92ad93509d4166bd025aed0b1b39a008
ToppCell	RA-11._Adipocyte\|World / Chamber and Cluster_Paper	PDE3B ACO1 GBE1 LDLRAD3 CLMP MMP19	2.78e-05	188	139	6	4dac9d636e5cad4cda540b93d4bfed6b5732c880
ToppCell	IPF-Epithelial-Club\|IPF / Disease state, Lineage and Cell class	SHROOM3 FOLR1 SGPP2 TACC2 NAV2 TMEM108	2.87e-05	189	139	6	f3fcef008ef252b29ac6d567fef27f9acf9cd70f
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 FAT4 LAMC1 NAV2 CLMP MMP19	2.95e-05	190	139	6	1121eb607a984c59fbffe7220837fc178745aa55
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 FAT4 LAMC1 NAV2 CLMP MMP19	2.95e-05	190	139	6	048b581e3f7ea9fc2f87c0532974bba85c7292c2
ToppCell	IPF-Epithelial-Club\|World / Disease state, Lineage and Cell class	SHROOM3 FOLR1 SGPP2 TACC2 NAV2 TMEM108	3.04e-05	191	139	6	3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TPSAB1 PDE3B SH2D2A CADPS IRS2 TPSB2	3.04e-05	191	139	6	468b5149d1533f03521844d3cce8633d44eb6ed4
ToppCell	COPD-Epithelial\|COPD / Disease state, Lineage and Cell class	SHROOM3 FOLR1 SGPP2 TACC2 C6orf132 NAV2	3.13e-05	192	139	6	0644fad5df18f0021f6f49cca996d8cf47f972ff
ToppCell	severe-Myeloid-Neutrophils_3\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	DOK3 MSL1 CD46 RPH3A IRS2 ITM2B	3.22e-05	193	139	6	f4d43dfbf4115dd0f843ea5cf08049220342a047
ToppCell	10x5'v1-week_12-13-Mesenchymal_fibro-stroma-arteriolar_fibroblast\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	THSD4 FLNC MINAR2 TACC2 CPT1C SLC25A48	3.22e-05	193	139	6	3d85c28f6ebdcb15e875ad01d52d6c138fbf8525
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SHROOM3 FOLR1 TACC2 NKX2-1 CCDC78 C6	3.22e-05	193	139	6	bdb7401dd9059032f930f2b575f2ef8e504b6594
ToppCell	3'_v3-Lung-Mast\|Lung / Manually curated celltypes from each tissue	TPSAB1 HSPG2 SIGLEC8 KIAA1549 CADPS TPSB2	3.32e-05	194	139	6	5e6eb81ddc9d5e22c1297734689f476d5a05bff6
ToppCell	severe-Myeloid-Neutrophils_3\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	DOK3 MSL1 CD46 RPH3A IRS2 ITM2B	3.32e-05	194	139	6	1f8edab1c8ba48bc0114429ea47aab378b5830b7
ToppCell	3'_v3-Lung-Mast-Mast_cells\|Lung / Manually curated celltypes from each tissue	TPSAB1 HSPG2 SIGLEC8 KIAA1549 CADPS TPSB2	3.32e-05	194	139	6	7b7f1714c4a9d9519c4d0e460cb87f2eb82392dd
ToppCell	10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	TPSAB1 SIGLEC8 KIAA1549 SEMA4C CADPS TPSB2	3.42e-05	195	139	6	fbedb9978ded857fd35c2a8664f7579f42edaa36
ToppCell	IPF-Epithelial\|IPF / Disease state, Lineage and Cell class	SHROOM3 SGPP2 TACC2 C6orf132 CCDC78 NAV2	3.52e-05	196	139	6	87d9881cfec461a5d89b688a83749b618c519485
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TPSAB1 SIGLEC8 DOK3 KIAA1549 CADPS TPSB2	3.62e-05	197	139	6	bed8a9b73af5caee51b1232b31c24a59353658df
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 FAT4 LAMC1 NAV2 CLMP MMP19	3.62e-05	197	139	6	85a8f1d18e0dd1d31341f5131eecd217553bf042
ToppCell	COPD-Stromal-Myofibroblast\|World / Disease state, Lineage and Cell class	FAT4 LAMC1 KANK2 NAV2 TMEM108 CLMP	3.62e-05	197	139	6	d51f484b4e01ac64233950d0b97fa88825ea1dbb
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 FAT4 LAMC1 NAV2 CLMP MMP19	3.62e-05	197	139	6	e8e3ba791dfaa0fab35e0329a5e34376f9ee6143
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Mast_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TPSAB1 SIGLEC8 DOK3 KIAA1549 CADPS TPSB2	3.62e-05	197	139	6	b7d5073d44aa1e2cb83ea8d8104c5ed662665755
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 FAT4 LAMC1 NAV2 CLMP MMP19	3.62e-05	197	139	6	9b480f9c799a244bfee64487abd8a1bf07c9a3a2
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 FAT4 LAMC1 NAV2 CLMP MMP19	3.72e-05	198	139	6	a860246bcea847249a78fd2e86ed8e04371060db
ToppCell	medial-2-Epithelial-Alveolar_Epithelial_Type_1\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	HSPG2 SHROOM3 FOLR1 TACC2 C6orf132 NKX2-1	3.83e-05	199	139	6	456460c761e26ed4b1d88d9bee4d2a7c9bd9d416
ToppCell	medial-Epithelial-Alveolar_Epithelial_Type_1-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	HSPG2 SHROOM3 FOLR1 TACC2 C6orf132 NKX2-1	3.83e-05	199	139	6	5263338242f95c04690d0795749ccc20b0d19f7a
ToppCell	distal-Epithelial-Alveolar_Epithelial_Type_1-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SHROOM3 FOLR1 TACC2 C6orf132 NKX2-1 NAV2	3.83e-05	199	139	6	c1daa481f88d5281b6b5ea8ec8bb70cc0907d613
ToppCell	medial-Epithelial-Alveolar_Epithelial_Type_1\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	HSPG2 SHROOM3 FOLR1 TACC2 C6orf132 NKX2-1	3.83e-05	199	139	6	c11365653c69a5dfb37946231f8af05149a61a71
ToppCell	Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	THSD4 HSPG2 FLNC FAT4 JAG2 NPC1L1	3.83e-05	199	139	6	6a2943a23fdd2ec814662db7c21a0d6804a6cbbc
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SHROOM3 PDE3B TRPM3 OGDHL NFAT5 PLXNB1	3.83e-05	199	139	6	3cd6383c50ce342fe5c175e2e50784d634a90e80
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	THSD4 SHROOM3 PCLO TACC2 RAVER2 LNX1	3.93e-05	200	139	6	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Mast_cell-Mast_cell\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	TPSAB1 SIGLEC8 KIAA1549 CADPS IRS2 TPSB2	3.93e-05	200	139	6	a338b2b94901e4614ef78e82f580b67891f7c849
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PDE3B GIT1 SMCHD1 RNF213 PCDH17 ITM2B	3.93e-05	200	139	6	79e51afb57ca38aacebd0298e5e727b55c0cfff9
ToppCell	Biopsy_Other_PF-Epithelial\|Biopsy_Other_PF / Sample group, Lineage and Cell type	SHROOM3 FOLR1 SGPP2 TACC2 NKX2-1 PLXNB1	3.93e-05	200	139	6	1ef4d5ae698fa721e0f510bf0d918bd8d3b00591
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PDE3B GIT1 SMCHD1 PCDH17 ARHGAP27 ITM2B	3.93e-05	200	139	6	b7533c571eeea0cb3678e1a57d3dc036fa8d0f49
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PDE3B GIT1 SMCHD1 RNF213 PCDH17 ITM2B	3.93e-05	200	139	6	a1fa6bae5a688faf488d6925cd3fad725dfa916b
ToppCell	LPS_IL1RA_TNF-Endothelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PDE3B GIT1 SMCHD1 RNF213 PCDH17 ITM2B	3.93e-05	200	139	6	d01cec331be3b03cef80e9536fc531285bcf00f6
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Mast_cell\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	TPSAB1 SIGLEC8 KIAA1549 CADPS IRS2 TPSB2	3.93e-05	200	139	6	21de2cf284c8d2aa464f3d403f0e292e1f654e0a
ToppCell	PBMC-Mild-cDC_2\|Mild / Compartment, Disease Groups and Clusters	THSD4 EPPK1 LAMC1 KIF24 TMEM108	6.58e-05	135	139	5	cb9d834f8301cf53f20e09c3f4cb6a148690196a
ToppCell	Severe-Myeloid-Mast-\|Severe / Condition, Lineage, Cell class and cell subclass	TPSAB1 SIGLEC8 CADPS TMEM108 TPSB2	9.22e-05	145	139	5	ce307d45425a5191882078f049f85477eec40b69
ToppCell	Severe-Myeloid-Mast\|Severe / Condition, Lineage, Cell class and cell subclass	TPSAB1 SIGLEC8 CADPS TMEM108 TPSB2	9.22e-05	145	139	5	e0bfd2ffdbd6c197ef0a04e983396ebd87ef7127
ToppCell	Children_(3_yrs)-Immune-mast_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TPSAB1 SIGLEC8 KIAA1549 CADPS TPSB2	9.53e-05	146	139	5	f7349d63bb47f1f22ced8ff514edc1c11bc782e7
ToppCell	356C-Myeloid-Mast_cell\|356C / Donor, Lineage, Cell class and subclass (all cells)	TPSAB1 SIGLEC8 DNAH2 CADPS TPSB2	1.02e-04	148	139	5	1668d8a9e680da335362744f36b05446c499347e
ToppCell	356C-Myeloid-Mast_cell-\|356C / Donor, Lineage, Cell class and subclass (all cells)	TPSAB1 SIGLEC8 DNAH2 CADPS TPSB2	1.02e-04	148	139	5	18511ba10765eda937c5a710626361f7e6b9b321
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RNF31 CIT SCART1 HHIPL1 TPSB2	1.08e-04	150	139	5	6f7087a051a2f05c5611ff65a945c01736d5ec2b
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	LRFN1 SMCHD1 PCDH17 MYL10 TPSB2	1.12e-04	151	139	5	b698ddc74565d47892c09c3f16d78038da2dd5e7
ToppCell	368C-Myeloid-Mast_cell\|368C / Donor, Lineage, Cell class and subclass (all cells)	TPSAB1 SIGLEC8 KIAA1549 CADPS TPSB2	1.15e-04	152	139	5	faf30245a1690aaa27c7be0832797c340e4af4d7
ToppCell	368C-Myeloid-Mast_cell-\|368C / Donor, Lineage, Cell class and subclass (all cells)	TPSAB1 SIGLEC8 KIAA1549 CADPS TPSB2	1.15e-04	152	139	5	519c9ed05fdaf420e42147ffae1dc05a7f86fdd4
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PDE3B SMCHD1 SGPP2 EVX2 PIK3IP1	1.19e-04	153	139	5	7480522a47e367f8facc4f5d599fbaf0b5ad4007
ToppCell	mild_COVID-19_(asymptomatic)-CD8+_T_naive\|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)	PDE3B LRFN1 SGPP2 PIK3IP1 SCART1	1.26e-04	155	139	5	e2c901d5c9e42d25d7702e5e8fc19b06f7c817be
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PDE3B SMCHD1 SGPP2 EVX2 PIK3IP1	1.30e-04	156	139	5	53ded973358e3e48054130131e959f0d1f4ef60f
ToppCell	Children_(3_yrs)-Immune-mast_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TPSAB1 SIGLEC8 KIAA1549 CADPS TPSB2	1.34e-04	157	139	5	ec185dbeabb67fd9ca85f71cab88463b60f9b1c1
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic-Mast_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TPSAB1 FLNC CADPS IRS2 TPSB2	1.46e-04	160	139	5	fe9970c160159b35f6599ed13c89cfb49264d554
ToppCell	PCW_13-14-Neuronal-Neuronal_postreplicative-neuro_immature_neuronal_(2)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	SH3TC2 CHRNA3 CELSR3 PRDM14 PCDH8	1.51e-04	161	139	5	bb9cb42882aaa4a1ecf9b480c0e7ac302f2c0d5d
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TPSAB1 ACO1 KIAA1549 TACC2 TPSB2	1.51e-04	161	139	5	1f4614ae15bd2fc08e555cea4d0152c4a940d048
Computational	Genes in the cancer module 486.	JAG2 SLC19A1 OGDHL TAF6 ALPK2 PLXNB1	6.68e-05	100	75	6	MODULE_486
Drug	0179445-0000 [211246-22-9]; Up 200; 1uM; PC3; HT_HG-U133A	RNGTT DSC2 CRTC1 SH2D2A TRPM3 RAVER2 MFSD13A DHX34 PRDM14	3.46e-06	198	138	9	4292_UP
Drug	Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A	PDE3B GIT1 CRTC1 PQBP1 CHRNA3 PIK3IP1 SLC19A1 MYL10 DHX34	3.75e-06	200	138	9	2323_DN
Disease	cortical thickness	THSD4 HSPG2 CPAMD8 SHROOM3 LAMC1 TACC2 ZNF318 SSBP3 ELAC2 PCDH17 C17orf58 JAG2 MRPL14 CADPS SLC19A1 NAV2 NAV1 CDK5RAP2 TMEM108 LNX1	1.77e-07	1113	135	20	EFO_0004840
Disease	Adenocarcinoma Of Esophagus	CDKN2A CRTC1 ARID1A	3.29e-05	14	135	3	C0279628
Disease	Generalized hypotonia	FCSK AGO1 TRPM3	4.09e-05	15	135	3	C1858120
Disease	Dysautonomia	TPSAB1 CHRNA3	6.21e-05	3	135	2	C0013363
Disease	seasonality measurement, vitamin D measurement	PDE3B SEC23A	2.06e-04	5	135	2	EFO_0004631, EFO_0006876
Disease	porphyria (implicated_via_orthology)	ACO1 GBE1	2.06e-04	5	135	2	DOID:13268 (implicated_via_orthology)
Disease	brain measurement, neuroimaging measurement	THSD4 LAMC1 SSBP3 ELAC2 C17orf58 JAG2 MRPL14 CADPS NAV2 LNX1	2.29e-04	550	135	10	EFO_0004346, EFO_0004464
Disease	neuroimaging measurement	THSD4 SHROOM3 LAMC1 TACC2 SSBP3 ELAC2 C17orf58 JAG2 MRPL14 CADPS NAV2 CC2D2A ARHGAP27 LNX1	4.02e-04	1069	135	14	EFO_0004346
Disease	age at menarche	DNAH2 CRTC1 SSBP3 ARID1A CHRNA3 GGT7 TRPM3 NKX2-1 TMEM108 NFAT5	4.21e-04	594	135	10	EFO_0004703
Disease	acute lymphoblastic leukemia (is_marker_for)	MYC CDKN2A CD46	5.05e-04	34	135	3	DOID:9952 (is_marker_for)
Disease	Seizures	FOLR1 SGSH CHRNA3 FCSK TRPM3 GOT2	5.17e-04	218	135	6	C0036572
Disease	uric acid measurement	FAT4 SHROOM3 ZNF318 ARID1A RPH3A GGT7 MED4 NAV1 MYL10 NFAT5	5.17e-04	610	135	10	EFO_0004761
Disease	Burkitt Lymphoma	MYC CDKN2A ARID1A	5.99e-04	36	135	3	C0006413
Disease	cortical surface area measurement, neuroimaging measurement	THSD4 SSBP3 C17orf58 JAG2 MRPL14 NAV2	6.39e-04	227	135	6	EFO_0004346, EFO_0010736
Disease	Glaucoma	CDKN2A CPAMD8	7.32e-04	9	135	2	C0017601
Disease	tryptase beta-2 measurement	TPSAB1 TPSB2	7.32e-04	9	135	2	EFO_0008306
Disease	neuroblastoma (is_implicated_in)	CDKN2A ARID1A	9.13e-04	10	135	2	DOID:769 (is_implicated_in)
Disease	Neuroblastoma	MYC CDKN2A ARID1A	1.31e-03	47	135	3	C0027819
Disease	FEV/FEC ratio	THSD4 HSPG2 CRTC1 MSL1 CHRNA3 C17orf58 CADPS SLC19A1 CPT1C NAV2 NAV1 HHIPL1 MYL10 LNX1	1.53e-03	1228	135	14	EFO_0004713
Disease	L2 Acute Lymphoblastic Leukemia	CDKN2A SLC19A1 PRDM14	1.57e-03	50	135	3	C0023453
Disease	Childhood Acute Lymphoblastic Leukemia	CDKN2A SLC19A1 PRDM14	1.76e-03	52	135	3	C0023452
Disease	pulse pressure measurement	THSD4 SHROOM3 CYP51A1 RNF213 CD46 ZNF318 RPH3A QSOX1 FCSK TRPM3 NAV1 HHIPL1 LNX1 NFAT5 DHX34	1.81e-03	1392	135	15	EFO_0005763
Disease	Carcinoma, Granular Cell	MYC CDKN2A FAT4 ARID1A	2.02e-03	116	135	4	C0205644
Disease	Adenocarcinoma, Tubular	MYC CDKN2A FAT4 ARID1A	2.02e-03	116	135	4	C0205645
Disease	Adenocarcinoma, Oxyphilic	MYC CDKN2A FAT4 ARID1A	2.02e-03	116	135	4	C0205642
Disease	Carcinoma, Cribriform	MYC CDKN2A FAT4 ARID1A	2.02e-03	116	135	4	C0205643
Disease	Adenocarcinoma, Basal Cell	MYC CDKN2A FAT4 ARID1A	2.02e-03	116	135	4	C0205641
Disease	Adenocarcinoma	MYC CDKN2A FAT4 ARID1A	2.02e-03	116	135	4	C0001418
Disease	caffeine measurement	LAMC1 CRTC1	2.10e-03	15	135	2	EFO_0021177
Disease	African Burkitt's lymphoma	MYC ARID1A	2.10e-03	15	135	2	C0343640
Disease	Burkitt Leukemia	MYC ARID1A	2.10e-03	15	135	2	C4721444
Disease	white matter microstructure measurement	EPPK1 SGPP2 C17orf58 PARP10 FAM120A NAV2 ARHGAP27	2.18e-03	390	135	7	EFO_0005674
Disease	red blood cell density measurement	THSD4 SHROOM3 ACO1 DNAH2 LAMC1 CRTC1 MED4 TRPM3 SLC19A1 CC2D2A IRS2	2.44e-03	880	135	11	EFO_0007978
Disease	Sjogren syndrome	SH2D2A NACC2 NFAT5	2.65e-03	60	135	3	EFO_0000699
Disease	Precursor Cell Lymphoblastic Leukemia Lymphoma	CDKN2A SLC19A1 PRDM14	2.78e-03	61	135	3	C1961102
Disease	Feeding difficulties	FCSK GOT2	3.03e-03	18	135	2	C0232466
Disease	Global developmental delay	FCSK AGO1 TRPM3 GOT2	3.31e-03	133	135	4	C0557874
Disease	osteochondrodysplasia (is_implicated_in)	HSPG2 DYM	3.38e-03	19	135	2	DOID:2256 (is_implicated_in)
Disease	cortical surface area measurement	THSD4 CPAMD8 SHROOM3 LAMC1 SSBP3 ELAC2 C17orf58 JAG2 MRPL14 CADPS NAV2 NAV1 ARHGAP27 LNX1	3.50e-03	1345	135	14	EFO_0010736
Disease	waist circumference	GBE1 RPH3A C17orf58 NAV2 NAV1 TMEM108 NFAT5	3.68e-03	429	135	7	EFO_0004342
Disease	urticaria	TPSAB1 TPSB2	3.74e-03	20	135	2	EFO_0005531
Disease	X-24309 measurement	HEATR4 TMEM108	3.74e-03	20	135	2	EFO_0800872
Disease	lung non-small cell carcinoma (is_implicated_in)	ARID1A CBL CHRNA3 PRDM14	3.88e-03	139	135	4	DOID:3908 (is_implicated_in)
Disease	Bladder Neoplasm	MYC CDKN2A ARID1A SLC19A1	3.98e-03	140	135	4	C0005695
Disease	Malignant neoplasm of urinary bladder	MYC CDKN2A ARID1A SLC19A1	4.08e-03	141	135	4	C0005684
Disease	anorexia nervosa	SGPP2 QSOX1 CELSR3	4.10e-03	70	135	3	MONDO_0005351
Disease	bilirubin measurement	FAT4 SGPP2 SH2D2A SSBP3 ARID1A RPH3A ROM1	4.33e-03	442	135	7	EFO_0004570
Disease	Autosomal Recessive Primary Microcephaly	CIT CDK5RAP2	4.52e-03	22	135	2	C3711387
Disease	Primary microcephaly	CIT CDK5RAP2	4.52e-03	22	135	2	C0431350
Disease	Hepatitis	FAT4 NAV2	4.52e-03	22	135	2	HP_0012115
Disease	Granulomatous Slack Skin	CDKN2A ARID1A	4.52e-03	22	135	2	C0376407
Disease	Nasopharyngeal carcinoma	CDKN2A ARID1A	4.52e-03	22	135	2	C2931822
Disease	pulse pressure measurement, alcohol consumption measurement	TACC2 LNX1	4.52e-03	22	135	2	EFO_0005763, EFO_0007878

Protein segments in the cluster

Peptide	Gene	Start	Entry
SPAGNIARNSPAARY	ACO1	681	P21399
PAVAAAAAQPGSYPA	ACSS1	46	Q9NUB1
AAAQPGSYPALSAQA	ACSS1	51	Q9NUB1
GSYPALSAQAAREPA	ACSS1	56	Q9NUB1
PLNYRGGARVEPADA	ALDH9A1	11	P49189
FAAAAPAQPGQVLER	C8orf74	201	Q6P047
LRAAAYSAQVQPVDG	C8orf33	181	Q9H7E9
SNEGNAQKPRPLYGA	CHRNA3	361	P32297
QGRYKLPTAPEAAEN	ALPK2	446	Q86TB3
PGLYQAPAAAAGLNS	EVX2	341	Q03828
SDNYGAPPGAAVQAR	FAT4	441	Q6V0I7
VNGSAFLPRNYLAPA	BTBD17	306	A6NE02
PVYADAAGTALPAAR	BTBD17	371	A6NE02
SGAAAGAYLPPLQQV	AGO1	6	Q9UL18
PDVNGRTPIDYARQA	GIT1	196	Q9Y2X7
PKPYPNSEAARAANN	CYC1	176	P08574
RAANNGALPPDLSYI	CYC1	186	P08574
YGARNPLDAGAAEPI	CIT	6	O14578
TAARLSYQNDPPFGS	DSC2	631	Q02487
QAASAPSRVAAVGPY	TP53BP2	336	Q13625
LLNAQPPVGAAYQDS	CDK5RAP2	1006	Q96SN8
APLAAYRQGQAAPPT	NKX2-1	36	P43699
PPFGDYAQVSSLRNE	RAVER2	636	Q9HCJ3
PSVSLGAAYRAQPSA	RBM14	241	Q96PK6
AAAYGAQPSATLAAP	RBM14	501	Q96PK6
PQFPAANQAENADYR	PCDH17	956	O14917
ANLAYPAGSTQPIRI	HSPG2	2331	P98160
GANAAPRSALYSPSD	QSOX1	26	O00391
NDNAPAFAQPEYRAS	PCDHGA12	236	O60330
PQASAEAPFAARGIY	KIAA1549	1786	Q9HCM3
GQPYGRSPSAVAAAA	ARID1A	151	O14497
PQLDAPISQFYADRA	CADPS	646	Q9ULU8
NRSLPYLPADIGNAE	GDAP2	231	Q9NXN4
QTQPGYANTLRDAAP	SLC25A3	191	Q00325
NQADLPPYRSRSGSA	LDLRAD3	286	Q86YD5
YIRDPLNGQAVPANG	CD46	101	P15529
AAVATFAQARPPGIY	RNGTT	151	O60942
NEPSADAPAALYQTI	ITM2B	101	Q9Y287
DPAAQPEVYALGVRN	HHIPL1	381	Q96JK4
NSFYLPPAGAAGDRA	JAG2	101	Q9Y219
TGAAQAPALPAQDHY	LRFN1	591	Q9P244
NQASFREAARAPAGP	C17orf58	86	Q2M2W7
YLDNLPNFNRSIDGP	GSPT2	416	Q8IYD1
ARNLVPRDNNGYSDP	PCLO	4716	Q9Y6V0
RPGDTQYVAANDPAV	PLXNB1	136	O43157
YLRGHINDSQAAPAP	GGT7	446	Q9UJ14
YVGRDPAAAPATGNR	OGDHL	971	Q9ULD0
EGLPGNLDAAVYSPR	MMP19	331	Q99542
QASLVRFPGGNYPAA	MINAR2	31	P59773
PALDSDVGPNSLQRY	PCDHGB2	156	Q9Y5G2
VRENNPPGAYLATVA	PCDH8	506	O95206
LQRSLGNAPNTPDFY	PDE3B	551	Q13370
PGSPLQFYVDAINSR	FLNC	1846	Q14315
AEYSQDSQRGTPARP	KIF24	731	Q5T7B8
NGQAPDAYRPRDDSF	LNX1	366	Q8TBB1
PGPANDSTLEAQYRR	DOK3	441	Q7L591
AAAATAYGPDARPGQ	HAND1	66	O96004
AFPPDVCGNLDYRNL	MYL10	201	Q9BUA6
QAAIQGRPPYAASAE	FAM120A	1011	Q9NZB2
ALAAGRLPDVLAPQY	MED4	206	Q9NPJ6
FAPANALPARSEAAA	PIK3IP1	131	Q96FE7
AAAPAGGNPEQRLDY	MSL1	11	Q68DK7
SARGLPAAQPLYAVV	NEURL2	216	Q9BR09
YTPDPAAAGALNVNV	NFAT5	541	O94916
PYLDNLPNFNRSVDG	GSPT1	286	P15170
YDQNPSPRAAGERDD	NUTM1	701	Q86Y26
LNNYPAGDPRLAQAK	NPC1L1	576	Q9UHC9
ADTTAAGPLFQQRPY	PQBP1	231	O60828
LPNGDYLNVSPSDAV	IRS2	761	Q9Y4H2
LYRLPPASAVATAQG	IRS2	1041	Q9Y4H2
RPAISPAYSNENAQG	NLGN3	671	Q9NZ94
NYSDLRQLPNAGPGA	C6orf132	1016	Q5T0Z8
YVTPTPLQAARAGNA	CPT1C	261	Q8TCG5
ARVIALPGSPAYAQN	FCSK	171	Q8N0W3
LLEAGALPNAPNSYG	CDKN2A	31	P42771
TPAARPEDYEAALNA	GBE1	6	Q04446
PFRAPNGDYSTASLQ	CC2D2A	1131	Q9P2K1
TSNPYRVPANLENVG	C6	226	P13671
LANLTDASDAPNPYR	DYM	291	Q7RTS9
APALQQYRTSAGSPA	CRTC1	441	Q6UUV9
AQAVLTAPYSLGRPD	FRMPD3	856	Q5JV73
NRNPPARKEAYGDIS	GALNT4	396	Q8N4A0
DGVRAAQPQAPGYLI	CPAMD8	21	Q8IZJ3
PAAYGEPLQAAASAL	F8A1;	111	P23610
DFNPDRYLQDNPASG	CYP51A1	426	Q16850
SAQAIPEASYRPVQG	HEATR4	396	Q86WZ0
EELLVAYRAPGNPQA	CCDC78	311	A2IDD5
AYRAPGNPQAIFDIA	CCDC78	316	A2IDD5
ASAKLPSRPADNYDN	IST1	306	P53990
AAGAPAQRAQSLEPY	KANK2	346	Q63ZY3
EGRPSAYNFDNSPVL	LAMC1	226	P11047
SLLRQGAEGAPSPNY	CBL	441	P22681
RATDGDAPPNANLRY	CELSR3	456	Q9NYQ7
RGLYPQLAVPDAFNS	DHX34	806	Q14147
YSALATPENGVNPAD	DNAH2	2291	Q9P225
APAQAPTLRQGCFYL	MFSD13A	456	Q14CX5
VYSQEPGAQPDLALA	PRRT3	261	Q5FWE3
PAQGNPNEEVARFYA	FOLR1	216	P15328
LSVQDRYSPPNADGH	PARP10	926	Q53GL7
EPGFLAPGARSNIQY	NAV1	656	Q8NEY1
PPDNQDAYRAEFGSL	TAF6	441	P49848
VLASRAYAAPAPGQA	TPSAB1	11	Q15661
AYAAPAPGQALQRVG	TPSAB1	16	Q15661
VLASRAYAAPAPGQA	TPSB2	11	P20231
AYAAPAPGQALQRVG	TPSB2	16	P20231
YSQASAAAPQPAAAR	RPH3A	356	Q9Y2J0
DYSAAAAPSPVLGNI	SSBP3	91	Q9BWW4
LNESNADTYAGRPLP	SMCHD1	796	A6NHR9
QPFRQLEAAASAAPA	PRDM14	51	Q9GZV8
NLGYTAASPQAPEAA	SH2D2A	36	Q9NP31
VDNSALGNSPYHRAP	MRPL14	41	Q6P1L8
SYQAARKDSGSPNPA	MYC	151	P01106
QLGQAERAAAGYPDP	EPPK1	1316	P58107
GYPPRANASRFINTE	NAV2	826	Q8IVL1
AQYVRELPALGNPAA	ARHGAP27	61	Q6ZUM4
DRPYQDAPVATNNPD	SIGLEC8	71	Q9NYZ4
AQSAYLQPGPAALEG	SHROOM3	1116	Q8TF72
YRLSGFESIQNPPND	SH3TC2	376	Q8TF17
KSRAVAPAEQPAYQG	SLC25A48	146	Q6ZT89
PAEQPGSFLYDARLQ	SEMA4C	596	Q9C0C4
VPNTPAARADLAAQY	SGSH	226	P51688
RNQFPPSYAGISELN	SEC23A	91	Q15436
PNLVGVAPSRAVYFA	SLC25A33	96	Q9BSK2
APANGLRRAAAPEAY	SGPP2	61	Q8IWX5
YAQRDGAAPTASAPR	B3GNT9	26	Q6UX72
YSNPPLNGARIAAAI	GOT2	316	P00505
DAAPQPGLATQAYSL	CLMP	321	Q9H6B4
DNSPGAYRSHPDNAI	CTDNEP1	186	O95476
LAGEDPPAYQARLLQ	RNF31	1041	Q96EP0
TPQAPLEAIQAYLAG	RNF213	1951	Q63HN8
RLAPQNGGSSDAPAY	TOR1AIP1	31	Q5JTV8
QEYRRSAQDGPAPAE	ELAC2	461	Q9BQ52
SAQDGPAPAEKRSQY	ELAC2	466	Q9BQ52
VGASRASLNAALYPP	ROM1	81	Q03395
VNAPQAIADRAAFPG	TRPM3	1581	Q9HCF6
YPRLALAQLPEDGSQ	TEDC1	91	Q86SX3
VGPASLEQRQSDPYL	SLC19A1	511	P41440
SDPYLAQAPAPQAAE	SLC19A1	521	P41440
VNYNAIGVDRPPRTA	FSBP	51	O95073
QQAYDAPAPSRGSVQ	SCART1	481	Q4G0T1
LRDNPAYDTPDAGAS	SH2B2	46	O14492
GNPEAVALAPDAYST	TACC2	2101	O95359
ASAEGLNPYGLVAPR	FERMT3	496	Q86UX7
APHALPNRNGSLSYD	ZDHHC8	466	Q9ULC8
PRSGLQAAEAPIYQL	THSD4	231	Q6ZMP0
ASQFAAARIPPNYQG	ZNF318	766	Q5VUA4
ERAAQLPRNTAPAGY	ZFPL1	81	O95159
ADANVRDKSYAGPLP	ZDHHC1	106	Q8WTX9
DQLSEPRSPANGDYR	TMEM108	536	Q6UXF1
GSRPQPAEAYAEAVQ	HECTD3	191	Q5T447
CNQLQPAAAAAAPYV	NACC2	146	Q96BF6